Nestle’s Galderma Skin-Care Buy Shows Health Challenge

Nestle SA paid $3.6 billion yesterday to take full control of Galderma, the dermatology business that revives skin. Nestle Chief Executive Officer Paul Bulcke will need to do the same at the unit to spur growth.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.